brefeldin
dramat
welldocu
effect
structur
function
organ
golgi
complex
examin
effect
brefeldin
bfa
golgiloc
synthesi
addit
chondroitin
sulfat
glycosaminoglycan
carbohydr
side
chain
bfa
caus
dosedepend
inhibit
chondroitin
sulfat
glycosaminoglycan
elong
sulfat
onto
core
protein
melanomaassoci
proteoglycan
major
histocompat
complex
class
iiassoci
invari
chain
presenc
bfa
melanoma
proteoglycan
core
protein
retain
er
still
acquir
complex
sialyl
nlink
oligosaccharid
measur
digest
endoglycosidas
h
neuraminidas
initi
glycosaminoglycan
syn
abstract
brefeldin
dramat
welldocu
effect
structur
function
organ
golgi
complex
examin
effect
brefeldin
bfa
golgiloc
synthesi
addit
chondroitin
sulfat
glycosaminoglycan
carbohydr
side
chain
bfa
caus
dosedepend
inhibit
chondroitin
sulfat
glycosaminoglycan
elong
sulfat
onto
core
protein
melanomaassoci
proteoglycan
major
histocompat
complex
class
iiassoci
invari
chain
presenc
bfa
melanoma
proteoglycan
core
protein
retain
er
still
acquir
complex
sialyl
nlink
oligosaccharid
measur
digest
endoglycosidas
h
neuraminidas
initi
glycosaminoglycan
synx
biosynthesi
glycosaminoglycan
gag
carbohydr
side
chain
involv
extens
seri
posttransl
enzymat
reaction
occur
dur
ing
intracellular
transport
core
protein
er
golgi
complex
reaction
use
specif
initi
elong
sulfat
enzym
modifi
appropri
core
protein
assembl
matur
proteoglycan
molecul
chondroitin
sulfat
cs
gag
carbohydrateprotein
linkag
region
initi
xylosyltransferas
transfer
xylos
udpxylos
hydroxyl
group
specif
serin
residu
within
core
protein
initi
complet
addit
oftwo
galactosyl
one
glucuronosyl
residu
action
galactosyltransferas
ii
glucuronosyltransferas
respect
initi
repeat
disaccharid
backbon
ofglucuronosyl
nacetylgalactosaminyl
residu
elong
specif
glucuronosyland
nacetylgalactosaminyltransferas
sulfat
repeat
disaccharid
complet
synthesi
monoor
disulf
cs
see
fig
summari
r
c
spird
current
address
telio
pharmaceut
inc
thesi
affect
bfa
shown
incorpor
galactos
proteincarbohydr
linkag
region
sensit
abil
cell
use
exogen
acceptor
pnitro
elong
sulfat
core
proteinfre
glycosaminoglycan
complet
inhibit
bfa
effect
bfa
complet
revers
absenc
new
protein
synthesi
experi
indic
bfa
effect
uncoupl
chondroitin
sulfat
glycosaminoglycan
synthesi
segreg
initi
reaction
elong
sulfat
event
find
support
propos
glycosaminoglycan
elong
sulfat
reaction
associ
transgolgi
network
bfaresist
golgi
subcompart
gener
accept
gag
synthesi
golgi
complexrel
event
earli
studi
use
electron
microscopi
radioautographi
show
golgi
complex
major
site
gag
chain
synthesi
golgienrich
prepar
isol
cell
type
also
shown
contain
gag
synthes
activ
recent
studi
examin
kinet
entri
ofradiolabel
sugar
gag
chain
well
local
gag
sugar
nucleotid
sulfat
donor
transport
system
clearli
local
gag
synthesi
golgi
complex
exact
spatial
organ
cascad
enzymat
reaction
involv
gag
synthesi
known
due
part
lack
understand
dynam
spatial
differenti
golgi
complex
golgi
complex
divid
least
four
distinct
region
ci
medial
transgolgi
transgolgi
network
tgn
specif
chang
induc
fungal
metabolit
brefeldin
bfa
provid
new
inform
structur
organ
golgi
complex
relat
function
ben
dramat
yet
revers
alter
golgi
morpholog
function
disrupt
bud
ofnonclathrinco
transport
vesicl
respons
anterograd
movement
result
block
anterograd
protein
transport
er
redistribut
ofci
medial
tramsgolgiresid
enzym
back
er
retrograd
microtubuledepend
pathway
contrast
compartment
process
involv
format
tgn
lysosom
endocyt
vesicl
resist
redistribut
induc
bfa
aim
studi
defin
dynam
topolog
gag
synthesi
use
bfa
human
melanomaassoci
proteoglycan
mpg
model
system
demonstr
bfa
revers
uncoupl
gag
chain
initi
elong
sulfat
event
presenc
ofbfa
mpg
core
protein
retain
er
acquir
complex
nlink
oligosaccharid
convert
cs
proteoglycan
form
addit
bfatreat
cell
fail
elong
sulfat
gag
chain
onto
exogen
artifici
gag
acceptor
odx
initi
gag
synthesi
presenc
bfa
proce
addit
xylosyl
residu
galactosyl
residu
carbohydrateprotein
linkag
region
result
indic
gag
chain
elong
sulfat
bfaresist
event
associ
tgn
ogalactosidas
chicken
liver
purchas
oxford
glycosystem
rosedal
new
york
c
glycopeptid
prepar
previous
describ
materi
reagent
grade
human
melanoma
cell
line
subclon
propag
laboratori
cell
line
provid
dr
l
morton
ucla
lo
angel
ca
human
melanoma
cell
line
provid
dr
j
trent
univers
michigan
ann
arbor
mi
human
blymphoblastoid
cell
line
raji
obtain
dr
n
theofilopoulo
scripp
research
institut
la
jolla
ca
cell
line
propag
rpmi
dme
cultur
media
supplement
fc
whittak
bioproduct
inc
walkersvil
md
mm
glutamin
tugml
gentamicin
sulfat
sigma
chemic
co
stock
solut
bfa
made
methanol
concentr
mgml
store
deoxymannojirimycin
made
stock
solut
mgml
cultur
media
cell
preincub
inhibitor
h
analysi
depend
upon
natur
experi
describ
figur
legend
signific
loss
viabil
cell
result
inhibitor
treatment
judg
trypan
blue
exclus
tcaprecipit
count
per
minut
methionin
incorpor
protein
mab
direct
mpg
core
protein
develop
describ
previous
rabbit
antibodi
direct
coohtermin
peptid
sequenc
class
iiassoci
invari
chain
provid
dr
vito
quaranta
scripp
research
institut
journal
cell
biolog
volum
la
jolla
ca
produc
describ
previous
sera
preimmun
rabbit
fusion
partner
cultur
supernat
serv
neg
control
immunoprecipit
experi
metabol
radiolabel
cell
surfac
iodin
immunoprecipit
specif
antigen
perform
describ
previous
quantit
sulfatelabel
macromolecul
carri
previous
describ
immunoprecipit
isol
mab
galactoselabel
cell
wash
extens
pb
contain
mgml
ovalbumin
h
galactoselabel
olink
oligosaccharid
releas
mpg
core
protein
treatment
tul
n
naoh
overnight
room
temperatur
releas
chain
neutral
acet
acid
evapor
three
time
mcohohac
remov
borat
salt
sampl
dilut
ml
tri
base
pass
column
qaesephadex
equilibr
mm
tri
neutral
speci
ran
column
start
materi
desalt
mix
bed
ion
exchang
resin
recoveri
neutral
oligosaccharid
analyz
anionexchang
column
use
gradient
acetonitril
mm
ph
min
flow
rate
mlmin
fraction
ml
count
run
includ
intern
standard
cfucitol
ovalbumin
glycopeptid
c
digest
carri
al
buffer
ph
h
use
u
enzym
immunofluoresc
microscopi
cell
grown
round
glass
coverslip
place
cultur
dish
pretreat
bfa
h
coverslip
wash
icecold
bsa
fix
immedi
paraformaldehyd
solut
sodium
phosphat
ph
min
ice
coverslip
wash
pb
follow
glycin
cell
surfac
immunofluoresc
block
permeabil
humanmous
chimer
form
mab
contain
human
heavi
light
chain
constant
region
wga
min
room
temperatur
fix
block
cell
permeabil
saponin
bsa
min
incub
primari
antibodi
h
room
temperatur
wash
coverslip
incub
fluoresc
label
antimous
secondari
antibodi
wga
h
room
temperatur
wash
mount
glass
slide
fluoromount
g
southern
biotechnolog
assoc
birmingham
al
mount
slide
view
ioox
oil
neofluor
len
microscop
carl
zeiss
inc
thornwood
ny
equip
barrier
filter
prevent
crossov
fluorescein
rhodamin
fluoresc
human
melanoma
mpg
antigen
recogn
mab
synthes
initi
precursor
con
tain
nlink
oligosaccharid
high
mannos
endo
hsensit
type
trim
process
nlink
oligosaccharid
complex
endo
hresist
sialyl
form
result
convers
compon
form
addit
gag
chain
core
protein
convert
high
molecular
mass
kd
proteoglycan
form
composit
mpg
gag
previous
shown
form
chondroitin
sulfat
molecular
mass
kd
treatment
human
melanoma
cell
increas
concentr
bfa
result
dosedepend
inhibit
convers
mpg
core
protein
cs
proteoglycan
form
fig
inhibit
becom
appar
ngml
complet
higher
concentr
effect
protein
synthesi
viabil
label
condit
concentr
ugml
data
shown
intermedi
form
core
protein
accumul
along
speci
presenc
bfa
higher
concentr
bfa
core
protein
convert
form
fig
high
molecular
mass
form
chondroitinas
abcsensit
form
data
shown
mpg
observ
presenc
bfa
suggest
inhibit
cs
gag
chain
elong
complet
inhibit
incorpor
sulfat
mpg
complex
also
consist
absenc
gag
chain
elong
sulfat
fig
left
panel
ident
result
obtain
three
addit
human
melanoma
cell
line
data
shown
spiro
complet
transport
assembl
mpg
complex
result
express
proteoglycan
compon
cell
surfac
truncat
form
speci
also
releas
cultur
media
spiro
r
unpublish
observ
mpg
form
could
isol
either
cell
surfacelabel
cell
trypsin
pretreat
bfa
methioninelabel
cultur
media
cell
fig
middl
right
panel
absenc
mpg
cell
surfac
express
releas
consist
arrest
intracellular
transport
core
protein
determin
subcellular
site
arrest
distribut
mpg
core
protein
presenc
bfa
examin
immunofluoresc
microscopi
mab
mpg
complex
show
local
perinuclear
stain
pattern
fix
permeabil
cell
stain
mab
fitcconjug
secondari
antibodi
fig
stain
pattern
typic
golgi
complex
confirm
coloc
tritc
conjug
distal
golgi
stack
marker
wga
fig
b
contrast
treatment
cell
bfa
fixat
permeabil
result
diffus
reticular
stain
pattern
typic
er
fig
c
golgispecif
wga
stain
also
becom
diffus
consist
bfainduc
morpholog
golgi
redistribut
fig
result
suggest
transport
mpg
core
protein
block
er
golgi
presenc
bfa
mpg
nlink
oligosaccharid
process
bfatreat
cell
bfainduc
effect
golgi
complex
previous
shown
caus
redistribut
ci
medial
transgolgiresid
enzym
back
er
examin
golgi
enzym
redistribut
bfatreat
melanoma
cell
process
mpg
core
protein
nlink
oligosaccharid
monitor
endo
h
digest
mpg
immunoprecipit
isol
cell
pretreat
puls
label
chase
presenc
bfa
immedi
puls
label
form
mpg
suscept
endo
h
digest
control
bfatreat
cell
min
throughout
remaind
chase
period
control
cell
precursor
convert
endo
hresist
form
high
molecular
mass
cs
proteoglycan
fig
bfatreat
cell
form
gradual
acquir
endo
h
resist
chase
period
beth
joumal
cell
biolog
volum
come
complet
resist
h
acquisit
endo
h
resist
accompani
slight
increas
molecular
mass
complet
convers
proteoglycan
form
inhibit
bfa
fig
neuraminidas
digest
mpg
isol
cell
label
e
methionin
h
chase
h
presenc
bfa
result
shift
mobil
core
protein
indic
acquisit
sialic
acid
residu
fig
b
result
consist
recycl
back
er
golgi
resid
enzym
trim
termin
process
nlink
oligosaccharid
erretain
mpg
core
protein
absenc
proteoglycan
form
mpg
suggest
redistribut
cs
gag
enzym
er
occur
redistribut
result
loss
function
activ
extent
cs
gag
chain
initi
occur
presenc
bfa
evalu
metabol
label
carbohydrateprotein
initi
linkag
region
h
galactos
pretreat
cell
dmj
use
inhibit
label
complex
nlink
oligosaccharid
therebi
limit
incorpor
h
galactos
exclus
olink
oligosaccharid
dmj
previous
shown
block
process
ofth
mpg
core
protein
nlink
oligosaccharid
high
mannos
stage
without
effect
convers
pro
teoglycan
form
fig
left
side
control
cell
label
h
galactos
label
incorpor
proteoglycan
form
mpg
complex
fig
right
side
cell
pretreat
dmj
incorpor
core
protein
form
block
partial
reduc
proteoglycan
form
cell
pretreat
bfa
also
incorpor
h
galactos
mpg
core
protein
even
presenc
dmj
fig
right
side
result
consist
addit
xylosyl
residu
least
one
galactosyl
residu
gag
carbohydrateprotein
linkag
region
presenc
bfa
precis
determin
effect
bfa
synthesi
carbohydrateprotein
linkag
region
h
galactoselabel
sugar
chain
releas
mpg
core
protein
size
charg
analyz
hplc
qaesephadex
ion
exchang
chromatographi
respect
releas
chain
neutral
two
peak
seen
hplc
analysi
fig
spiro
digest
elimin
peak
gener
monosaccharid
peak
presum
free
galactos
elut
slightli
later
standard
expect
major
peak
probabl
linkag
region
minor
peak
probabl
chromatographi
qaesephadex
show
label
materi
carri
one
three
neg
charg
base
comparison
appropri
standard
data
shown
character
ident
materi
report
elsewher
result
suggest
bfainduc
block
mpg
gag
chain
elong
sulfat
due
complet
block
initi
event
evalu
activ
gag
chain
enzym
machineri
presenc
bfa
independ
mpg
core
protein
treat
cell
test
abil
elong
sulfat
gag
chain
onto
exogen
acceptor
artifici
gag
acceptor
diffus
freeli
cell
site
gag
synthesi
substitut
xylos
residu
initi
linkag
region
allow
polymer
sulfat
gag
onto
smaller
odxbound
gag
effici
exocytos
cultur
media
sinc
initi
elong
prerequisit
sulfat
integr
gag
chain
enzym
machineri
evalu
independ
core
protein
structur
monitor
increas
incorpor
sulfat
macromolecul
presenc
repres
experi
incub
cell
mm
result
increas
mean
fig
proport
smacromolecul
releas
cultur
media
increas
presenc
repres
exocytosi
free
gag
chain
contrast
pretreat
cell
bfa
result
dosedepend
inhibit
incorpor
sulfat
macromolecul
observ
inhibit
due
block
uptak
sinc
ident
result
obtain
cell
preload
bfa
treatment
data
shown
ngnll
bfa
incorpor
sulfat
control
cell
higher
concentr
pgml
inhibit
virtual
complet
incorpor
diminish
control
cell
fig
similar
experi
perform
galactos
demonstr
accumul
h
galactos
intermedi
link
data
shown
dose
respons
rang
demonstr
correl
well
observ
fig
inhibit
convers
mpg
core
protein
proteoglycan
form
result
indic
bfa
complet
disrupt
abil
cell
use
exogen
artifici
acceptor
elong
sulfat
gag
chain
determin
bfa
perman
damag
gag
enzym
machineri
revers
effect
test
absenc
presenc
new
protein
synthesi
effect
bfa
synthesi
mpg
proteoglycan
form
complet
revers
cell
pretreat
bfa
min
pulselabel
min
wash
chase
absenc
bfa
convers
mpg
core
protein
proteoglycan
form
begin
h
releas
bfa
fig
overnight
releas
cs
proteoglycan
form
isol
bfatreat
cell
demonstr
chondroitinas
abc
digest
immunoprecipit
sdspage
analysi
fig
hour
time
point
interestingli
recoveri
bfa
treatment
higher
proport
mpg
express
rather
proteoglycan
form
indic
core
protein
accumul
presenc
bfa
serv
substrat
chondroitin
sulfat
synthesi
remov
drug
revers
bfainduc
effect
requir
new
protein
synthesi
ident
result
obtain
cell
treat
bfa
releas
condit
protein
synthesi
inhibit
cycloheximid
data
shown
effect
bfa
abil
cell
use
exogen
acceptor
also
complet
revers
cell
pretreat
bfa
releas
drugfre
media
h
incorpor
sulfat
gag
chain
level
equal
control
cell
ident
result
obtain
cell
releas
presenc
cycloheximid
fig
revers
absenc
new
protein
synthesi
indic
gag
elong
sulfat
enzym
present
inact
bfatreat
cell
address
gener
bfainduc
inhibit
gag
chain
synthesi
effect
convers
current
model
posttransl
addit
gag
chain
propos
synthesi
matur
occur
intracellular
vesicular
transport
core
protein
er
golgi
complex
assembl
process
requir
precis
coordin
tempor
spatial
paramet
influenc
core
protein
access
initi
elong
sulfat
enzym
previou
studi
shown
agent
disrupt
vesicular
transport
inhibit
core
protein
releas
er
also
inhibit
gag
chain
addit
mpg
core
protein
littl
effect
odxdepend
gag
synthesi
howev
interpret
previou
result
restrict
limit
data
effect
agent
structur
function
integr
vesicular
pathway
associ
organel
welldefin
effect
bfa
make
possibl
delin
topolog
cs
gag
enzymat
machineri
figur
effect
bfa
odxiniti
gag
synthesi
revers
cell
pretreat
h
without
bfa
wgml
rnm
label
sulfat
one
aliquot
cell
h
treatment
harvest
cellassoci
hatch
region
exocytos
nonhatch
region
quantit
describ
figur
second
aliquot
ofcel
result
present
studi
demonstr
golgispecif
chang
induc
bfa
profound
effect
cs
gag
synthesi
bfa
caus
dosedepend
yet
complet
revers
inhibit
cs
gag
elong
sulfat
onto
mpg
invari
chain
core
protein
well
onto
exogen
artifici
gag
acceptor
odx
bfa
affect
initi
cs
gag
synthesi
includ
addit
xylosyl
residu
galactosyl
residu
initi
linkag
region
simplest
explan
find
cs
gag
chain
elong
sulfat
enzym
resist
insensit
redistribut
induc
bfa
initi
enzym
fig
result
complet
uncoupl
cs
gag
chain
initi
elong
sulfat
event
manner
complet
analag
bfainduc
uncoupl
glycosphingolipid
synthesi
strongest
line
evid
support
idea
bfa
uncoupl
cs
gag
synthesi
come
experi
demonstr
gag
initi
absenc
elong
sulfat
analyz
incorpor
h
galactos
carbohydrateprotein
linkag
region
condit
incorpor
restrict
oligosaccharid
treatment
dmj
label
incorpor
mpg
core
protein
accumul
presenc
bfa
fig
sinc
gag
chain
repres
major
oligosaccharid
mpg
complex
incorpor
h
galactos
bfatreat
core
protein
consist
addit
xylosyl
residu
galactosyl
residu
initi
linkag
region
result
fine
structur
analysi
indic
galactos
predomin
incorpor
neutral
speci
sensit
digest
probabl
repres
linkag
region
fig
portion
materi
anion
ident
report
elsewher
complet
inhibit
odxdepend
cs
gag
chain
polymer
sulfat
induc
bfa
also
consist
uncoupl
gag
synthesi
xylos
analogu
diffus
freeli
cell
substitut
normal
carbohydrateprotein
linkag
residu
anterograd
intracellular
transport
molecul
golgi
complex
result
format
core
protein
free
gag
chain
effici
exocytos
cell
presenc
bfa
molecul
diffus
er
becom
properli
initi
due
redistribut
enzym
bfasensit
compart
cs
gag
synthesi
quickli
recov
within
h
complet
recoveri
absenc
new
protein
synthesi
proof
elong
sulfat
enzym
present
segreg
initi
enzym
bfatreat
cell
possibl
explan
inhibit
cs
gag
synthesi
induc
bfa
includ
direct
inhibit
elong
sulfat
enzym
absenc
redistribut
proper
nucleotid
sugar
sulfat
donor
transport
system
either
mechan
would
result
observ
inhibit
cs
gag
synthesi
regardless
locat
elong
sulfat
enzym
bfainduc
redistribut
howev
result
previou
studi
argu
possibl
bfa
inhibit
vitro
activ
sever
glycosyltransferas
affect
uptak
udpsugar
addit
sialyl
mpg
core
protein
presenc
bfa
demonstr
golgiresid
cmpsialic
acid
transport
system
sialytransferas
redistribut
er
recent
data
demonstr
bfa
caus
disrupt
golgispecif
structur
protein
suggest
mode
action
direct
toward
structur
integr
golgi
rather
resid
enzym
reason
like
bfainduc
inhibit
cs
gag
synthesi
due
segreg
initi
elongationsulf
enzym
bfa
sensit
resist
compart
respect
fig
result
present
strongli
support
propos
cs
gag
chain
elong
sulfat
tgnassoci
event
follow
directli
result
chege
pfeffer
show
tgn
bfaresist
golgi
subcompart
local
cs
elong
sulfat
event
tgn
extend
list
tgnresid
enzym
includ
specif
glycosyland
sulfotransferas
involv
reaction
previous
shown
class
sialyltransferas
synthas
local
bfaresist
compart
structur
studi
specif
enzym
involv
reaction
help
determin
mechan
respons
specif
target
tgn
map
cs
gag
elong
sulfat
tgn
complet
consist
previou
kinet
studi
gag
synthesi
exact
site
initi
xylosyl
reaction
debat
gener
agre
elong
sulfat
later
golgi
event
result
present
distinguish
er
earli
golgi
site
gag
initi
clearli
segreg
gag
elong
sulfat
import
determin
whether
similar
topolog
exist
synthesi
class
gag
tgn
differ
cismedi
transgolgi
function
sort
protein
transport
vesicl
bound
distinct
organel
domain
cell
surfac
interest
specul
addit
gag
side
chain
might
influenc
packag
core
protein
distinct
transport
vesicl
bound
differ
region
cell
express
core
protein
mpg
invari
chain
glycoprotein
proteoglycan
form
may
ultim
reflect
distinct
subcellular
local
andor
function
grate
sandoz
pharmaceut
basel
switzerland
gift
brefeldin
